Peterson Christine Tara, Denniston Kate, Chopra Deepak
1 Department of Family Medicine and Public Health, UC San Diego School of Medicine, Center of Excellence for Research and Training in Integrative Health , La Jolla, CA.
2 Chopra Foundation , Department of Ayurveda and Yoga Research, Carlsbad, CA.
J Altern Complement Med. 2017 Aug;23(8):607-614. doi: 10.1089/acm.2017.0083. Epub 2017 Jul 11.
The aim of this article is to review the current literature on the therapeutic uses and efficacy of Triphala. Herbal remedies are among the most ancient medicines used in traditional systems of healthcare such as Ayurveda. Triphala, a well-recognized and highly efficacious polyherbal Ayurvedic medicine consisting of fruits of the plant species Emblica officinalis (Amalaki), Terminalia bellerica (Bibhitaki), and Terminalia chebula (Haritaki), is a cornerstone of gastrointestinal and rejuvenative treatment.
A search of the PubMed database was conducted.
In addition, numerous additional therapeutic uses described both in the Ayurvedic medical literature and anecdotally are being validated scientifically. In addition to laxative action, Triphala research has found the formula to be potentially effective for several clinical uses such as appetite stimulation, reduction of hyperacidity, antioxidant, anti-inflammatory, immunomodulating, antibacterial, antimutagenic, adaptogenic, hypoglycemic, antineoplastic, chemoprotective, and radioprotective effects, and prevention of dental caries. Polyphenols in Triphala modulate the human gut microbiome and thereby promote the growth of beneficial Bifidobacteria and Lactobacillus while inhibiting the growth of undesirable gut microbes. The bioactivity of Triphala is elicited by gut microbiota to generate a variety of anti-inflammatory compounds.
This review summarizes recent data on pharmacological properties and clinical effects of Triphala while highlighting areas in need of additional investigation and clinical development.
本文旨在综述有关三果木(Triphala)治疗用途及疗效的当前文献。草药疗法是阿育吠陀等传统医疗体系中使用最古老的药物之一。三果木是一种广为人知且高效的阿育吠陀复方草药,由余甘子(Emblica officinalis,印度醋栗)、毗黎勒(Terminalia bellerica)和诃子(Terminalia chebula)的果实组成,是胃肠道和恢复性治疗的基石。
对PubMed数据库进行了检索。
此外,阿育吠陀医学文献中描述的以及坊间传闻的许多其他治疗用途正在得到科学验证。除了通便作用外,三果木的研究发现该配方在多种临床应用中可能有效,如刺激食欲、降低胃酸过多、抗氧化、抗炎、免疫调节、抗菌、抗诱变、适应原性、降血糖、抗肿瘤、化学保护和辐射防护作用,以及预防龋齿。三果木中的多酚调节人体肠道微生物群,从而促进有益双歧杆菌和乳酸杆菌的生长,同时抑制不良肠道微生物的生长。三果木的生物活性由肠道微生物群引发,产生多种抗炎化合物。
本综述总结了三果木药理特性和临床效果的最新数据,同时强调了需要进一步研究和临床开发的领域。